Studies have consistently shown that elevated Lp(a) levels correlate with an increased risk of coronary artery disease, ischemic stroke, and peripheral artery disease, making it a significant marker for cardiovascular risk assessment [13-15]. This evidence concerns the gene LPA and peripheral arterial disease.